Filings For: Immix Biopharma, Inc.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics
GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
Immix Biopharma, Inc. (IMMX) 8/7/2026 5:15:42 PM Small View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $239,108,896 EPS -$0.18
Immix Biopharma, Inc. (IMMX) 5/7/2026 5:22:01 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $95,816,057 EPS -$0.18
Immix Biopharma, Inc. (IMMX) 4/6/2026 4:38:07 PM   View Proxy SEC Y 2025
Immix Biopharma, Inc. (IMMX) 3/27/2026 5:35:38 PM Micro View Financials 10-K/A SEC Y 2025 ending: 12/31/2025 Assets $104,840,341 EPS -$0.89
Immix Biopharma, Inc. (IMMX) 3/25/2026 5:21:56 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $104,840,341 EPS -$0.89
Immix Biopharma, Inc. (IMMX) 11/7/2025 5:36:52 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $20,080,604 EPS -$0.24
Immix Biopharma, Inc. (IMMX) 8/8/2025 5:33:19 PM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $15,635,104 EPS -$0.22
Immix Biopharma, Inc. (IMMX) 5/19/2025 5:32:25 PM Micro View Financials 10-Q/A SEC 1Q 2025 ending: 3/31/2025 Assets $19,892,040 EPS -$0.15
Immix Biopharma, Inc. (IMMX) 5/19/2025 5:22:24 PM Micro View Financials 10-K/A SEC Y 2024 ending: 12/31/2024 Assets $22,947,872 EPS -$0.76
Immix Biopharma, Inc. (IMMX) 5/8/2025 4:44:49 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $19,892,040 EPS -$0.15
Immix Biopharma, Inc. (IMMX) 4/30/2025 6:02:09 AM   View Proxy SEC Y 2024
Immix Biopharma, Inc. (IMMX) 3/25/2025 6:15:46 AM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Assets $22,947,872 EPS -$0.76
Immix Biopharma, Inc. (IMMX) 11/12/2024 4:45:12 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Assets $25,141,552 EPS -$0.24
Immix Biopharma, Inc. (IMMX) 8/12/2024 5:26:21 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Assets $28,835,944 EPS -$0.15
Immix Biopharma, Inc. (IMMX) 5/9/2024 4:36:59 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Assets $34,347,592 EPS -$0.22
Immix Biopharma, Inc. (IMMX) 4/29/2024 5:40:29 PM   View Proxy SEC Y 2023
Immix Biopharma, Inc. (IMMX) 3/29/2024 4:17:08 PM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023 Assets $19,925,160 EPS -$0.89
Immix Biopharma, Inc. (IMMX) 11/13/2023 6:18:43 AM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Assets $22,474,778 EPS -$0.23
Immix Biopharma, Inc. (IMMX) 8/11/2023 4:46:17 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Assets $15,566,487 EPS -$0.24
Immix Biopharma, Inc. (IMMX) 5/12/2023 5:13:45 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $13,211,467
Immix Biopharma, Inc. (IMMX) 4/25/2023 4:54:04 PM   View Proxy SEC Y 2022
Immix Biopharma, Inc. (IMMX) 3/27/2023 4:28:50 PM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Assets $14,908,101
Immix Biopharma, Inc. (IMMX) 11/9/2022 4:29:38 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $17,395,039
Immix Biopharma, Inc. (IMMX) 8/12/2022 4:32:23 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $19,088,038
Immix Biopharma, Inc. (IMMX) 5/13/2022 5:22:23 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Assets $20,017,498
Immix Biopharma, Inc. (IMMX) 4/25/2022 9:16:00 AM   View Proxy SEC Y 2021
Immix Biopharma, Inc. (IMMX) 3/28/2022 5:46:54 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Assets $18,192,088